Corisma

Bethany, United States

Corisma develops a catheter implanted circulatory assist device designed to treat patients suffering from advanced heart failure.

$27.0M raised

Aug 2021

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Corisma raised?

Corisma has raised $27.0M in total funding. The most recent round was Series A. The last funding was announced in August 2021.

Who are Corisma's investors?

Corisma's investors include Propel(X), China Grand Pharmaceutical and Healthcare Holdings.

Where is Corisma headquartered?

Corisma is headquartered in Bethany, United States.

What does Corisma do?

Corisma develops a catheter implanted circulatory assist device designed to treat patients suffering from advanced heart failure.

What stage is Corisma at?

Corisma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 30, 2021.

MLA

"Corisma — Funding & Investors." VCBacked, August 30, 2021, https://www.vcbacked.co/company/corisma. Accessed July 3, 2026.

APA

VCBacked. (2021). Corisma — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/corisma

Wikipedia (cite web)

{{cite web |title=Corisma — Funding & Investors |url=https://www.vcbacked.co/company/corisma |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 30, 2021.